BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 38275828)

  • 21. Prognostic factors in uveal melanoma.
    Singh AD; Shields CL; Shields JA
    Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance options for patients with uveal melanoma following definitive management.
    Francis JH; Patel SP; Gombos DS; Carvajal RD
    Am Soc Clin Oncol Educ Book; 2013; ():382-7. PubMed ID: 23714555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
    Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
    Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uveal melanoma in patients with ocular or oculodermal melanocytosis].
    Szuścik I; Romanowska-Dixon B; Jakubowska B; Orłowska-Heitzman J
    Klin Oczna; 2008; 110(10-12):380-3. PubMed ID: 19195171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveal Melanoma - Standardised Procedure in Diagnosis, Therapy and Surveillance.
    Bechrakis NE; Bornfeld N; Heindl LM; Skoetz N; Leyvraz S; Joussen AM
    Klin Monbl Augenheilkd; 2021 Jul; 238(7):761-772. PubMed ID: 34376006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture.
    Shields JA; Shields CL
    Ophthalmology; 2015 Feb; 122(2):414-28. PubMed ID: 25439609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uveal melanoma: updated considerations on current management modalities.
    Manschot WA; Lee WR; van Strik R
    Int Ophthalmol; 1995-1996; 19(4):203-9. PubMed ID: 8737700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the clinical management of uveal melanoma.
    Carvajal RD; Sacco JJ; Jager MJ; Eschelman DJ; Olofsson Bagge R; Harbour JW; Chieng ND; Patel SP; Joshua AM; Piperno-Neumann S
    Nat Rev Clin Oncol; 2023 Feb; 20(2):99-115. PubMed ID: 36600005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on Ophthalmic Oncology 2014: Retinoblastoma and Uveal Melanoma.
    Francis JH; Levin AM; Abramson DH
    Asia Pac J Ophthalmol (Phila); 2016; 5(5):368-82. PubMed ID: 27632029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of uveal melanomas, guidelines for oncologists].
    Mathis T; Cassoux N; Tardy M; Piperno S; Gastaud L; Dendale R; Maschi C; Nguyen AM; Meyer L; Bonnin N; Baillif S; Tick S; Mouriaux F; Jaspart F; Dellis J; Rosier L; Desjardins L; Herault J; Caujolle JP; Thariat J
    Bull Cancer; 2018 Oct; 105(10):967-980. PubMed ID: 30217336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for uveal melanoma metastasis. Literature review.
    Missotten GS; Keunen JE
    Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case of Metastatic Uveal Melanoma: From Diagnosis to Survival Four Years Later.
    Chandra S; McKean H
    S D Med; 2023 Mar; 76(3):120-123. PubMed ID: 36898198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.
    Dalvin LA; Zhang Q; Hamershock RA; Chang M; Yu MD; Mashayekhi A; Shields CL
    Br J Ophthalmol; 2020 May; 104(5):697-702. PubMed ID: 31409650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Management of Uveal and Conjunctival Melanoma.
    Blum ES; Yang J; Komatsubara KM; Carvajal RD
    Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical Analysis of Uveal Melanoma].
    Nezu N; Goto H; Umazume K; Ueda S; Shibata M
    Nippon Ganka Gakkai Zasshi; 2017 May; 121(5):413-8. PubMed ID: 30074750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current molecular and clinical insights into uveal melanoma (Review).
    Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.